APA

Voss M. H., Hierro C., Heist R. S., Cleary J. M., Meric-Bernstam F., Tabernero J., Janku F., Gandhi L., Iafrate A. J., Borger D. R., Ishii N., Hu Y., Kirpicheva Y., Nicolas-Metral V., Pokorska-Bocci A., Vaslin Chessex A., Zanna C., Flaherty K. T. & Baselga J. (20200619). A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Voss Martin H, Hierro Cinta, Heist Rebecca S, Cleary James M, Meric-Bernstam Funda, Tabernero Josep, Janku Filip, Gandhi Leena, Iafrate A John, Borger Darrell R, Ishii Nobuya, Hu Youyou, Kirpicheva Yulia, Nicolas-Metral Valerie, Pokorska-Bocci Anna, Vaslin Chessex Anne, Zanna Claudio, Flaherty Keith T and Baselga Jose. 20200619. A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Voss M. H., Hierro C., Heist R. S., Cleary J. M., Meric-Bernstam F., Tabernero J., Janku F., Gandhi L., Iafrate A. J., Borger D. R., Ishii N., Hu Y., Kirpicheva Y., Nicolas-Metral V., Pokorska-Bocci A., Vaslin Chessex A., Zanna C., Flaherty K. T. and Baselga J. (20200619). A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Voss Martin H, Hierro Cinta, Heist Rebecca S, Cleary James M, Meric-Bernstam Funda, Tabernero Josep, Janku Filip, Gandhi Leena, Iafrate A John, Borger Darrell R, Ishii Nobuya, Hu Youyou, Kirpicheva Yulia, Nicolas-Metral Valerie, Pokorska-Bocci Anna, Vaslin Chessex Anne, Zanna Claudio, Flaherty Keith T and Baselga Jose. A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20200619.